1. Academic Validation
  2. Identification of O-GalNAc-modified proteins interacting with GALNT3 using proximity labeling method

Identification of O-GalNAc-modified proteins interacting with GALNT3 using proximity labeling method

  • Carbohydr Res. 2025 Sep 20:558:109675. doi: 10.1016/j.carres.2025.109675.
Bo Xu 1 Mingzhu Zhang 2 You Yu 1 Mengjiao Yang 1 Zhenwang Zhang 2 Mingjie Wei 2 Shigang Shan 1 He Zhu 3 Yanting Su 4
Affiliations

Affiliations

  • 1 School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, China.
  • 2 School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, China.
  • 3 Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China; Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, 430030, China. Electronic address: whtjzhuhe@163.com.
  • 4 School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, China. Electronic address: 2014202040134@whu.edu.cn.
Abstract

Protein glycosylation is a widely occurring post-translational modification catalyzed by glycosyltransferases and is involved in various biological functions. O- N-acetylgalactosamine (O-GalNAc) modification is catalyzed by the N-acetylgalactosaminyltransferase (GALNT) family and represents a truncated form of O-glycosylation, which is closely associated with the development of various diseases. The O-GalNAc modification has long been considered to occur exclusively within the secretory pathway, targeting only membrane and secreted proteins. However, recent study has reported the nuclear localization of GALNT3, suggesting that O-GalNAc modification can also occur in the nucleus. Currently, there is no comprehensive glycoproteomic characterization of O-GalNAc modifications in the nucleus. Here, we employed an efficient proximity labeling approach based on a mutant biotin Ligase, TurboID. By generating a fusion of GALNT3 with TurboID, biotin labeling was performed in living cells, enabling the biotinylation of proteins that interact with GALNT3. Using this strategy, delineated 25 high-confidence and 10 potential O-GalNAc-modified sites across 26 characterized proteins and 4 uncharacterized proteins. Additionally, 52 putative O-GalNAc-modified peptides originating from 33 distinct proteins and 19 uncharacterized proteins were identified. The majority of which were nuclear-localized and reported to be O-GalNAc-modified for the first time.

Keywords

GALNT3; O-GalNAc; Proximity labeling; TurboID.

Figures
Products